Human Being Redux

TWO YEARS AGO, AS ONE OF THE MEMBERS OF
the President's Council on Bioethics, I and others on the Council outlined a logic for letting therapeutic cloning go forward. Then, as now, few favor reproductive cloning-cloning for baby-making. But cloning for biomedical research, a process that only involves cells in a petri dish and may well ultimately relieve human suffering, is another matter. Now South Korean scientists have made a major advance in biomedical cloning ("Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst," W. S. Hwang et al., Reports, 12 March, p. 1669; published online 12 Feb., 10.1126/science.1094515). They have shown the world that therapeutic cloning that allows for the production of stem cells, which may lead to remedies for human diseases, is possible. The hopes raised by this advance belie the fear, raised 2 years ago by those against letting the American biomedical community into this scientific hunt, that biomedical cloning would undermine the dignity of the human race. Indeed, the one million Americans who suffer from Parkinson's disease would undoubtedly feel more affronted if these advances had not taken place.
How did we get to the point where the United States, one of the world's great scientific powers, is sitting on the sidelines while this work is being done? At the center of the discussion is the belief on the part of some that a blastocyst, the entity in the petri dish, is morally equivalent to a living postnatal human being. The human embryo, the entity created by the union of an egg and sperm, carries all the genetic information of a member of the human species. Thus, those opposed to therapeutic cloning consider the embryo a human being. Of course, to develop into a human being, the embryo must be implanted into the uterus of a woman and be allowed to develop. This potential to become a human being is what sticks in the minds of the supporters of the moral equivalence argument and persuades them that manipulation of embryos for anything but normal reproduction is not acceptable.
Looking at a miniscule ball of cells in a petri dish, so small that it could rest on the head of a pin, one may be hard pressed to think of it as a human being. After all, it has no brain or capacity to think and feel. Merely possessing the genetic material for a future human being does not make a ball of cells a human being. The developing embryo that becomes a fetus that becomes a baby is the product of a dynamic interaction with its in vivo environment, its postnatal experiences, and a host of other factors. A pure genetic description of the human species does not describe a human being. A human being represents a more complex level of organization, as distinct from a simple embryo as an embryo is distinct from an egg and sperm. It is the dynamics between genes and environment that make a human being.
The South Korean scientists seem to understand these distinctions. They are not in the baby-making business. They have constructed a fence around developing embryos through a cloning process unfolding in a petri dish. Their embryos are allowed to develop for only a few days, at which time the all-important stem cells are harvested for possible therapeutic use, and simultaneously the rest of the cell mass dies. There is no slippery slope here; there is no beginning of the much-feared world of cloned humans. The South Korean scientists have found a way to let biomedical cloning go forward with all of its spectacular promise for restoring human dignity to the seriously diseased and infirm patients of the world, while avoiding the creation of a social atmosphere that might use such advances for baby making. What could be better?
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LETTERS
Exaggerated scenarios serve only to intensify the existing polarization over global warming. What is needed is not more words but rather a means to shut down CO 2 emissions to the atmosphere. "
-BROECKER
"
The United States can solve its dilemma quickly and easily. Forensic science professionals heartily support research into the scientific underpinnings of forensic science. Daubert and subsequent cases have changed the way courts review knowledge-based evidence. It is therefore not unreasonable for courts to demand that nonacademic-based procedures be shown to be reliable by scientists independent of law enforcement laboratories. The challenge is to ensure that the methods and techniques that protect the innocent and incriminate the guilty are reliable and actually work.
The Consortium of Forensic Science Organizations (CFSO) represents over 11,000 individuals who work in forensic science worldwide. These organizations and their members endorse the notion that their work must be grounded in scientific principles. The CFSO endorses research into the underpinnings of forensic science techniques. However, money is needed to fund that research. Congress must provide the National Institute of Justice (NIJ) with adequate resources and a mandate to undertake the research needed to demonstrate the validity and reliability of these techniques. Other funding agencies that have not traditionally funded forensic research, such as the National Science Foundation, should also be engaged. Research conducted by impartial scientists working in research institutes, coupled with input from the forensics community, is needed.
Will research quiet the naysayers to forensic science? Probably not, but carefully directed research aimed at some of the key problems will promote fairness in our justice system and lead to ever more powerful and reliable technology. Now for the hard part: How can the scientific/academic community, in cooperation with the forensics community, put these issues on the radar screen of those who can provide appropriate funding? (2) . Thus, rodents (low trophic level, small body size) have larger genomes than carnivores (high trophic level, moderate/large body size): 0.539 ± 0.007 versus 0.478 ± 0.025, respectively (MannWhitney, P < 10 −3 ). Insectivores (high trophic level, small body size) also have larger genomes than carnivores: 0.553 ± 0.013 versus 0.478 ± 0.025, respectively (P < 10 −6 ). Artiodactyls (low trophic level, large body size) have smaller genomes than rodents: 0.508 ± 0.026 versus 0.539 ± 0.009, respectively (P < 0.1). Thus, both the effect of trophic level and body size argue against Lynch and Conery's model. By reverse inference, this test supports the adaptive interpretation of genome enlargement.
Response WE THANK VINOGRADOV FOR HIS COMMENTS on our Report, in which we called attention to the population-genetic mechanisms that may have been responsible for the dramatic genomic reorganization that occurred in the stem eukaryote and the subsequent modifications experienced in lineages of multicellular species.
As a possible means to test the theory further, we somewhat cavalierly suggested comparisons of related carnivore and herbivore species, invoking ecological reasoning that suggests that the former should generally have reduced effective population sizes. Although Vinogradov argues that our theory is not supported in mammalian species, there are several concerns with his analysis.
First, the Animal Genome Size Database (AGSD) contains multiple entries for several species and numerous genera are represented by more than one species. Moreover, given the close relationships of the members of individual lineages relative to the time scale of genomic evolutionary events, the data employed cannot be regarded as phylogenetically independent. Because the true lineagespecific means may be substantially different than the estimates presented, and the standard errors will certainly be much larger, no conclusions on the importance of selection can be derived from the data as presented.
Second, a more thorough test would ideally consider issues such as intron number and size and mobile-element abundance, rather than focus on the less illuminating measure of total genome size. We certainly do not rule out adaptive evolution as a mechanism in genome evolution, and it is conceivable that the evolution of carnivory promotes the expansion of genome size through the proliferation of various gene families that facilitate this way of living.
Third, the theory that we present is meant to explain broad patterns. Because evolution and population dynamics are stochastic processes, we expect to find significant scatter around the general expectations, and ample evidence of this can be found in our Report. Thus, the above caveats aside, work of this sort should be based on multiple independent contrasts between herbivores and carnivores, large-and small-body-sized species, and so forth.
Finally, there is a real need to formally evaluate, with molecular marker data, whether carnivores do in fact have reduced effective population sizes. This is a potentially significant issue in mammals, where groups with different dietary habits can also have rather different mating systems and population dynamics. News of the Week: "In sex reversal, protein deterred by nuclear barrier" by A. Sreenivasan (19 Dec., p. 2050). The article described work by David Jans and colleagues demonstrating for the first time that specific mutations in the SRY protein prevent it from binding to importin β or calmodulin, and that this, in turn, impairs the import of SRY into the nucleus. These and other mutations in SRY had previously been linked to a rare syndrome in which babies are born with a male set of chromosomes and female sexual organs. The article stated that the Jans group's work is the "first demonstration that a clinical syndrome can be caused by a molecule's inability to get into the nucleus." However, Michael Weiss and colleagues reported in 2001 that a specific SRY mutation impairs the molecule's ability to enter the nucleus, and concluded that "these results provide the first example of impaired organogenesis due to a nuclear localization signal mutation" ( J. Biol. Chem., 7 Dec. 2001, p. 46480). 
